Early Inclisiran Use in Atherosclerotic Cardiovascular Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early Inclisiran Use in Atherosclerotic Cardiovascular Disease

Published:2024-05 Issue:20 Volume:83 Page:1953-1956
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Shapiro Michael D.^ORCID,German Charles A.^ORCID

Publisher

Elsevier BV

Reference13 articles.

1. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals;Underberg;Postgrad Med,2022

2. An “inclisiran first” strategy vs usual care in patients with atherosclerotic cardiovascular disease.;Koren;J Am Coll Cardiol,2024

3. Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials;Patti;Eur Heart J Cardiovasc Pharmacother,2022

4. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol;Grundy;J Am Coll Cardiol,2019

5. 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease Risk;Lloyd-Jones;J Am Coll Cardiol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3